Keyphrases
Benign Lesion
14%
Benign Thyroid Disease
28%
Cell Cycle Regulators
100%
Cyclin D1 (CCND1)
42%
Cyclin E
42%
Derangement
14%
Diagnostic Utility
100%
Differentiated Thyroid Cancer
100%
Distant Metastasis
14%
Extrathyroidal
14%
Favorable Outcome
14%
Histology
14%
Local Recurrence
14%
Lymph Node
28%
Lymph Node Involvement
14%
Molecular Markers
14%
Murine Double Minute 2 (MDM2)
14%
No Significant Difference
14%
P16 Expression
28%
Poor Outcome
14%
Precancerous Lesions
14%
Prognostic Utility
100%
Statistical Analysis
14%
Thyroid Cancer Diagnosis
14%
Thyroid Cancer Prognosis
14%
Thyroid Lesions
14%
Thyroid Tumor
14%
Tissue Microarray
14%
Tumor Behavior
28%
Tumor Extension
14%
Medicine and Dentistry
Cancer Diagnosis
14%
Cancer Prognosis
14%
Cell Cycle
100%
Cyclin D1
42%
Cyclin E
42%
Diagnosis
100%
Differentiated Thyroid Cancer
100%
Disease
14%
Distant Metastasis
14%
Lymph Node
42%
Malignant Neoplasm
28%
Mdm2
14%
Molecular Marker
14%
Neoplasm
42%
P16
85%
P21
42%
Protein P53
14%
Recurrent Disease
14%
Thyroid Gland
42%
Thyroid Tumor
14%
Tissue Microarray
14%
Biochemistry, Genetics and Molecular Biology
Cell Cycle
100%
Cyclin D1
50%
Cyclin E
50%
Genetic Marker
16%
Mdm2
16%
P16
100%
P21
50%
P53
16%
Tissue Microarray
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclin D1
42%
Cyclin E
42%
Differentiated Thyroid Cancer
100%
Disease
14%
Distant Metastasis
14%
Malignant Neoplasm
28%
Molecular Marker
14%
Neoplasm
42%
Protein P53
14%
Recurrent Disease
14%
Thyroid Tumor
14%
Veterinary Science and Veterinary Medicine
P53
14%
Thyroid
57%
Thyroid Cancer
100%